Associate Professor, Pathology and Immunology, Washington University School of Medicine in St. Louis
Dr. Kate Schwetye aims to model the progression of AD pathology by using cutting-edge technologies never before used in the living human brain. The results will offer fresh perspectives that can enhance our grasp of tau and amyloid pathology, potentially speeding up the development of new drugs and providing valuable information for clinical trials.